Sales decline 28.02% to Rs 203.67 crore
Net Loss of Orchid Pharma reported to Rs 63.74 crore in the quarter ended March 2016 as against net loss of Rs 148.05 crore during the previous quarter ended March 2015. Sales declined 28.02% to Rs 203.67 crore in the quarter ended March 2016 as against Rs 282.94 crore during the previous quarter ended March 2015.For the full year,net loss reported to Rs 274.27 crore in the year ended March 2016 as against net loss of Rs 191.04 crore during the previous year ended March 2015. Sales declined 49.43% to Rs 866.11 crore in the year ended March 2016 as against Rs 1712.67 crore during the previous year ended March 2015.
ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales203.67282.94 -28 866.111712.67 -49 OPM %23.6030.73 -21.8821.10 - PBDT-14.11-17.51 19 -95.56-174.77 45 PBT-49.16-77.78 37 -238.97-496.14 52 NP-63.74-148.05 57 -274.27-191.04 -44
Powered by Capital Market - Live News
